CavarocchiNCEnglandMDSchaffHVOxygen free radical generation during cardiopulmonary bypass: correlation with complement activation. Circulation. 1986;74(5 pt 2):III130-III133.
2.
GauduelYMenaschePDuvelleroyM. Enzyme release and mitochondrial activity in reoxygenated cardiac muscle: relationship with oxygen-induced lipid peroxidation. Gen Physiol Biophys. 1989;8(4):327-340.
3.
BuckbergGD.Studies of hypoxemic/rexoygenation injury: I. Linkage between cardiac function and oxidant damage. J Thorac Cardiovasc. 1995;110(4 pt 2):1164-1170.
4.
TeohKHMickleDAWeiselRDEffect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. J Thorac Cardiovasc Surg. 1992;104(1):159-164.
5.
Del NidoPJMickleDAGWilsonGEvidence of myocardial free radical injury during elective repair of oftetralogy of Fallot. Circulation. 1987;76(5 pt 2):174-179.
6.
MoritaKIhnkenKBuckbergGDShermanMPYoungHH. Studies of hypoxemic/reoxygenation injury: without aortic cross clamping. IX. Importance of avoiding perioperative hyperoxemia in the setting of previous cyanosis. J Thorac Cardiovasc Surg. 1995;110(4 pt 2):1235-1244.
7.
MoritaKIhnkenKBuckbergGD. Studies of hypoxemic/reoxygenation injury: with aortic clamping. XII. Delay of cardiac reoxygenation damage in the presence of cyanosis: a new concept of controlled cardiac reoxygenation. J Thorac Cardiovasc Surg. 1995;110(4 pt 2):1265-1273.
8.
MoritaKIhnkenKBuckbergGDShermanMPYoungHHIgnarroLJ. Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts. J Clin Invest. 1994;93(6):2658-2666.
9.
AllenBSRahmanSIlbawiMNDetrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. Ann Thorac Surg. 1997;64(5):1381-1388.
10.
BulutcuFSBayndirOPolatBYalcinYÖZbekUCakaliE. Does normoxemic cardiopulmonary bypass prevent myocardial reoxygenation injury in cyanotic children?J Cardiothorac Vasc Anesth. 2002;16(3):330-333.
11.
ModiPImuraHCaputoMCardiopulmonary bypass-induced myocardial reoxygenation injury in pediatric patients with cyanosis. J Thorac Cardiovasc Surg. 2002;124(5):1035-1036.
12.
ToramanFEvrenkayaSSenaySAdjusting oxygen fraction to avoid hyperoxemia during cardiopulmonary bypass. Asian Cardiovasc Thorac Ann. 2007;15(4):313-316.
13.
ZhuZQSuZKZhuDMXuZWYangYMJiangZM. The role of graded reoxygenation with cardiopulmonary bypass in prevention of reoxygenation injury and its safety. Zhonghua Yi XueZaZhi. 9;85(9):614-617.
14.
SiegmundBKlietzTSchwartzPTemporary contractile blockade prevents hypercontracture in anoxic-reoxgenatedcardiomyocytes. Am J Physiol. 1991;260(2 pt 2):H426-435.
15.
CaputoMMokhtariARogersCAThe effects of normoxic versus hyperoxiccardiopulmonarybypass on oxidative stress and inflammatory response in cyanotic pediatric patients undergoing open cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg. 2009;138(1):206-214.
16.
BandaliKSBelangerMPWittnichiC. Does hyperoxia affect glucose regulation and transport in the newborn?J Thorac Cardiovasc Surg. 2003;126:1730-1735.
17.
JoachimssonPOSjobergFForsmanMAdverse effects of hyperoxemia during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1996;112(3):812-819.
18.
IhnkenKWinklerASchlensakCNormoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg. 1998;116(2):327-334.
19.
Abdel-RahmanURisteskiPTiziKHypoxic reoxygenation during initial reperfusion attenuates cardiac dysfunction and limits ischemia-reperfusion injury after cardioplegic arrest in a porcine model. J Thorac Cardiovasc Surg. 2009;137(4):978-982.
